Skip to main content
Caplight Logo









Camallergy

Camallergy

Private
CambridgeHealthcare & Life Scienceshttps://camallergy.com

Last Round

Grant

Jan 30, 2023

Total Funding Raised

$5.07M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Camallergy operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Grant round in January 2023.

Camallergy is a biopharmaceutical company that provides innovative, patient-centric treatments to address food allergies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Medical Devices

Business Model

B2B

Customer Profile

Hardware + Subscription, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Camallergy Comparables

Compare Camallergy with similar companies based on industry and business-model similarity.

Camallergy comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aravax
83%
Intrommune Therapeutics
83%
Prota Therapeutics
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Camallergy Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 30, 2023
GrantMar 9, 2021
AngelNov 7, 2017
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Andrew Clark

Co-founder & Chief Medical Officer

Founding Team

For institutional investors. Book with your work email.

Camallergy Investors

Notable investors and investment history

Camallergy investors
InvestorRounds
Innovate UKGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 174% MoM.

  • Jan 30, 2023

    $2.47M grant received from Innovate UK.

Book a demo to see all signals

For institutional investors. Book with your work email.

Camallergy Filings

Explore SEC and related filing metadata, where available.

Camallergy filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Camallergy's valuation, stock price, and market status.

Is Camallergy a public or private company?

Camallergy is a private company.

What is the current stock price of Camallergy?

Camallergy is a private company, so its shares have no public market price. Caplight tracks Camallergy's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Camallergy worth (valuation)?

Valuation information for Camallergy is not publicly available.

Can I buy Camallergy stock?

Camallergy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Camallergy's last funding round?

Camallergy's most recent funding round was Grant on January 30, 2023.

Who are the main investors in Camallergy?

Key investors in Camallergy include Innovate UK.

Will Camallergy IPO soon?

No public IPO plans have been announced for Camallergy.

How can I track Camallergy secondary market activity?

Caplight tracks bids, offers, and trades in Camallergy's shares on secondary markets.

Firmographic Details

HeadquartersCambridge
Employee Range14
Year Founded2015
Last FundingJan 30, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?